Skip to main content
Clinical Trials/NCT02752477
NCT02752477
Unknown
Phase 3

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Pain in Chronic Pain Patients Undergoing Spinal Surgery: A Pilot Study

Ben Lim1 site in 1 country30 target enrollmentAugust 2, 2016

Overview

Phase
Phase 3
Intervention
Opioid-free general anesthetic
Conditions
Chronic Pain
Sponsor
Ben Lim
Enrollment
30
Locations
1
Primary Endpoint
Quantified opioid-consumption
Last Updated
6 years ago

Overview

Brief Summary

The objective of this trial is to determine whether an opioid-free general anesthetic (OFA) technique utilizing ketamine, dexmedetomidine, and lidocaine infusions can help reduce postoperative pain in opiate-dependent chronic pain patients (CPPs) undergoing spine surgery when compared with traditional opioid-containing techniques. It is expected that this OFA regimen will have a measurable reduction on postoperative opioid consumption and pain scores in CPPs.

Registry
clinicaltrials.gov
Start Date
August 2, 2016
End Date
September 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ben Lim
Responsible Party
Sponsor Investigator
Principal Investigator

Ben Lim

Anesthesiologist

University of Saskatchewan

Eligibility Criteria

Inclusion Criteria

  • Chronic pain \> 6 months, opiate-using patients scheduled for thoracic or lumbar spinal surgery

Exclusion Criteria

  • Pregnant or breastfeeding women, significant hepatic, renal or cardiac disease, allergy to any of the study drugs, inability to consent, respond to pain assessments or use the patient controlled analgesia device

Arms & Interventions

Opioid-free anesthetic (OFA) group

Intervention: Opioid-free general anesthetic

Traditional Anesthesia (TA) group

Intervention: Traditional general anesthetic

Outcomes

Primary Outcomes

Quantified opioid-consumption

Time Frame: 48 hours following surgery

Secondary Outcomes

  • Time of stay in post-anesthetic care unit (PACU)(up to 5 hours following surgery)
  • Visual analogue scale (VAS) pain scores(48 hours following surgery)
  • Incidence of adverse events(48 hours following surgery)

Study Sites (1)

Loading locations...

Similar Trials